About Syneron Medical (NASDAQ:ELOS)
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: N/A
- Symbol: NASDAQ:ELOS
- CUSIP: N/A
- Web: syneron-candela.com
- 50 Day Moving Avg: $10.90
- 200 Day Moving Avg: $10.14
- 52 Week Range: $6.18 - $11.43
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 21.15
- P/E Growth: 0.00
- Net Margins: -1.09%
- Return on Equity: -1.74%
- Return on Assets: -1.30%
- Current Ratio: 2.68%
- Quick Ratio: 1.84%
- Average Volume: 797,289 shs.
- Beta: 1.25
Frequently Asked Questions for Syneron Medical (NASDAQ:ELOS)
What is Syneron Medical's stock symbol?
Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."
How were Syneron Medical's earnings last quarter?
Syneron Medical Ltd. (NASDAQ:ELOS) posted its quarterly earnings results on Thursday, August, 4th. The company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.03. The business earned $75 million during the quarter, compared to the consensus estimate of $75.72 million. Syneron Medical had a negative net margin of 1.09% and a negative return on equity of 1.74%. The firm's revenue for the quarter was up 2.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.07 earnings per share. View Syneron Medical's Earnings History.
Where is Syneron Medical's stock going? Where will Syneron Medical's stock price be in 2017?
2 brokers have issued 1-year target prices for Syneron Medical's stock. Their predictions range from $11.00 to $11.00. On average, they expect Syneron Medical's share price to reach $11.00 in the next twelve months. View Analyst Ratings for Syneron Medical.
Who are some of Syneron Medical's key competitors?
Some companies that are related to Syneron Medical include Baxter International (BAX), Zimmer Biomet Holdings (ZBH), C.R. Bard (BCR), Align Technology (ALGN), DENTSPLY SIRONA (XRAY), STERIS PLC (STE), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), Hill-Rom Holdings (HRC), VWR Corporation (VWR), Integra LifeSciences Holdings Corporation (IART), DexCom (DXCM), ICU Medical (ICUI), LivaNova PLC (LIVN), Neogen Corporation (NEOG), NuVasive (NUVA), Nevro Corp. (NVRO) and Haemonetics Corporation (HAE).
Who are Syneron Medical's key executives?
Syneron Medical's management team includes the folowing people:
- Shimon Eckhouse Ph.D., Chairman of the Board
- Amit Meridor, Chief Executive Officer
- Hugo Goldman, Chief Financial Officer
- Erik Dowell, Vice President-North America
- William Griffing, Chief Executive Officer - Syneron Candela North America
- Shlomo Alkalay, Chief Operating Officer
- Lisa A. Soderquist, Chief Human Resource Officer
- Robert Ruck, Executive Vice President, Asia Pacific
- Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
- Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy
How do I buy Syneron Medical stock?
Shares of Syneron Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Syneron Medical's stock price today?
MarketBeat Community Rating for Syneron Medical (NASDAQ ELOS)MarketBeat's community ratings are surveys of what our community members think about Syneron Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Syneron Medical stock can currently be purchased for approximately $11.00.
Consensus Ratings for Syneron Medical (NASDAQ:ELOS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Hold Rating, 1 Buy Rating|
|Consensus Rating:||Buy (Score: 2.50)|
|Consensus Price Target: ||$11.00 (0.00% downside)|Consensus Price Target History for Syneron Medical (NASDAQ:ELOS)
Analysts' Ratings History for Syneron Medical (NASDAQ:ELOS)
(Data available from 10/24/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|5/12/2017||Maxim Group||Downgrade||Buy -> Hold||$12.00 -> $11.00||Medium|
|10/24/2016||Brean Capital||Reiterated Rating||Buy||N/A|
|8/5/2016||Leerink Swann||Downgrade||Outperform -> Market Perform||$9.40 -> $7.80||N/A|
Earnings History for Syneron Medical (NASDAQ:ELOS)Earnings History by Quarter for Syneron Medical (NASDAQ ELOS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/15/2017||Q416||$0.03||($0.03)||$82.02 million||$82.90 million||View||Listen|
|11/9/2016||Q316||($0.02)||$0.02||$68.08 million||$71.50 million||View||Listen|
|8/4/2016||Q216||$0.06||$0.09||$75.72 million||$75.00 million||View||Listen|
|5/19/2016||Q116||$0.01||$0.04||$64.38 million||$68.70 million||View||Listen|
|2/22/2016||Q415||$0.07||$0.07||$75.56 million||$78.90 million||View||Listen|
|11/11/2015||Q315||$0.03||$0.03||$66.60 million||$62.10 million||View||Listen|
|8/4/2015||Q215||$0.06||$0.04||$70.93 million||$73.50 million||View||N/A|
|5/13/2015||Q115||$0.01||$0.02||$62.08 million||$63.40 million||View||Listen|
|2/18/2015||Q414||$0.06||$0.09||$71.42 million||$74.10 million||View||N/A|
|11/12/2014||Q314||$0.03||$0.03||$58.32 million||$60.30 million||View||N/A|
|8/6/2014||Q214||$0.07||$0.07||$63.52 million||$64.60 million||View||Listen|
|5/14/2014||Q114||$0.04||$0.04||$55.50 million||$56.80 million||View||N/A|
|2/20/2014||Q413||$0.08||$0.11||$65.70 million||$64.30 million||View||Listen|
|11/13/2013||Q313||$0.01||$0.04||$62.06 million||$62.70 million||View||Listen|
|8/14/2013||Q2 2013||$0.09||$0.02||$70.93 million||$68.80 million||View||N/A|
|5/22/2013||Q1 2013||$0.02||$0.02||$61.19 million||$61.20 million||View||N/A|
|2/12/2013||Q4 2012||$0.09||$0.11||$70.60 million||$72.80 million||View||N/A|
|11/7/2012||Q312||$0.04||$0.03||$65.51 million||$60.13 million||View||N/A|
Earnings Estimates for Syneron Medical (NASDAQ:ELOS)
Current Year EPS Consensus Estimate: $0.33 EPS
Next Year EPS Consensus Estimate: $0.52 EPS
Dividend History for Syneron Medical (NASDAQ:ELOS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Syneron Medical (NASDAQ:ELOS)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Syneron Medical (NASDAQ:ELOS)
Latest Headlines for Syneron Medical (NASDAQ:ELOS)
Loading headlines, please wait.
Syneron Medical (ELOS) Chart for Tuesday, October, 24, 2017